Chemicals and pharmaceuticals · ARCT

Arcturus Therapeutics Holdings Inc.

12 filings mentioning 4 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
4topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

Across 12 filings we hold, Arcturus Therapeutics Holdings Inc. has written down 4 of the topics we track. That places it 112 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

ARCT Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something Arcturus Therapeutics Holdings Inc. has written into a filing. Not what they said. What applies once they have said it.

ISO 27001:202242
GDPR26
Code of Conduct on Data Protection for Research (GDPR Article 40)12
COSO Internal Control9
PCAOB AS 22014
UK GDPR (UK General Data Protection Regulation)3
IFRS 172

7 frameworks, 98 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Internal Control9
Restatement3
Material Weakness2
Records Retention1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Internal Control92024-04-05
Restatement32024-06-14
Material Weakness22020-03-27
Records Retention12022-11-09

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24

Recent filings

FiledFormItem
2024-06-148-KDirector or officer departure, Shareholder vote, Financial statements and exhibitsfiling
2024-04-058-KChange of accountant, Financial statements and exhibitsfiling
2022-11-0910-Qfiling
2022-06-248-KEntry into a material agreement, Shareholder vote, Financial statements and exhibitsfiling
2020-12-088-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2020-07-298-KEntry into a material agreement, Financial statements and exhibitsfiling
2020-04-178-KEntry into a material agreement, Item 1.02, Other material eventfiling
2020-03-278-KEntry into a material agreement, Financial statements and exhibitsfiling
2019-09-278-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2019-08-058-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2019-08-028-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2019-06-208-KEntry into a material agreement, Item 3.02, Director or officer departurefiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition